Infectious encephalitis in elderly patients: a prospective multicentre observational study in France 2016-2019
Paul Petitgas,Pierre Tattevin,Alexandra Mailles,Pierre Fillâtre,Jean-Paul Stahl,ENCEIF scientific committee, investigators group,Sophie Abgrall,Laurent Argaud,Xavier Argemi,Nathalie Asseray,Guillaume Baille,Aurélie Baldolli,Julien Biberon,Charlotte Biron,Geneviève Blanchet-Fourcade,Mathieu Blot,Anne Bonnetain,Elisabeth Botelho-Nevers,Frédéric Bourdain,David Boutoille,Hélène Brasme,Cédric Bruel,Fabrice Bruneel,Rodolphe Buzele,Etienne Canouï,Philippe Casenave,Bernard Castan,Charles Cazanave,Céline Cazorla,Thibault Challan-Belval,Pascal Chavanet,Catherine Chirouze,Tomasz Chroboczek,Johan Courjon,Thomas Broucker,Arnaud Blanchardière,Etienne Montmollin,Thècle Degroote,Marine Delaroche,Eric Denes,Colin Deschanvres,Capucine Diard-Detoeuf,Aurélien Dinh,Olivier Epaulard,Pierre Fillatre,Emmanuel Forestier,Thibault Fraisse,Marie Froidure,Benjamin Gaborit,Amandine Gagneux-Brunon,Nicolas Gaillard,Arnaud Galbois,Mathieu Godement,François Goehringer,Simon Gravier,Valentin Greigert,Isabelle Gueit,Thomas Guimard,Carole Henry,Maxime Hentzien,Jean-Etienne Herbrecht,Pierre Jaquet,Fanny Jommier,Lydie Katchatourian,Solene Kerneis,Jessica Krause,Manuela Cam,Marion Maréchal,Gwenael Moal,Paul Turnier,Raphael Lecomte,Anne-Sophie Lecompte,Romain Lefaucheur,Stéphanie Lejeune,Xavier Lescure,Olivier Lesieur,Philippe Lesprit,Guillaume Louis,Christelle Lucas,Rafael Mahieu,Alain Makinson,Guillaune Marc,Alexandre Maria,Nathalie Marin,Aurélie Martin,Guillaume Martin-Blondel,Martin Martinot,Alexandre Mas,Philippe Mateu,Morgan Matt,Laurence Maulin,Frédéric Mechai,Jean-Paul Mira,Eugénie Mutez,Jérémie Orain,Anne Schieber-Pachart,Nathalie Pansu,Solene Patrat-Delon,Patricia Pavese,Hélène Pelerin,Véronique Pelonde-Erimée,Isabelle Pierre,Diane Ponscarme,Dimitri Psimaras,Mathilde Puges,Mathilde Reveillon-Istin,Sylvain Rheims,Aurélie Richard-Mornas,Agnès Riché,Vincent Roubeau,Yvon Ruch,Isabelle Runge,Hélène Savini,Romain Sonneville,Kelly Tiercelet,Saber Touati,Jean-Marie Turmel,Isabelle Tyvaert,Marc-Olivier Vareil,Magalie Vidal-Roux,Virginie Vitrat,Heidi Wille,Mathieu Zuber,Laurent Almoyna-Martinez,Olivier Bouchaud,Nadine Girard,Jean-Louis Herrmann,Jérome Honnorat,Patrice Morand,François Raffi,France Roblot
DOI: https://doi.org/10.1007/s15010-022-01927-3
Infection
Abstract:Purpose: Data on encephalitis in elderly patients are scarce. We aimed to describe the characteristics, aetiologies, management, and outcome of encephalitis in patients older than 65 years. Methods: We performed an ancillary study of ENCEIF, a prospective cohort that enrolled all cases of encephalitis managed in 46 clinical sites in France during years 2016-2019. Cases were categorized in three age groups: (1) 18-64; (2) 65-79; (3) ≥ 80 years. Results: Of the 494 adults with encephalitis enrolled, 258 (52%) were ≥ 65 years, including 74 (15%) ≥ 80 years. Patients ≥ 65 years were more likely to present with coma, impaired consciousness, confusion, aphasia, and rash, but less likely to present with fever, and headache (P < 0.05 for each). Median cerebrospinal fluid (CSF) white cells count was 61/mm3[13-220] in 65-79 years, 62 [17-180] in ≥ 80 years, vs. 114 [34-302] in < 65 years (P = 0.01). The proportion of cases due to Listeria monocytogenes and VZV increased after 65 years (P < 0.001), while the proportion of tick-borne encephalitis and Mycobacterium tuberculosis decreased with age (P < 0.05 for each). In-hospital mortality was 6/234 (3%) in < 65 years, 18/183 (10%) in 65-79 years, and 13/73 (18%) in ≥ 80 years (P < 0.001). Age ≥ 80 years, coma on admission, CSF protein ≥ 0.8 g/L and viral encephalitis were independently predictive of 6 month mortality. Conclusion: Elderly patients represent > 50% of adults with encephalitis in France, with higher proportion of L. monocytogenes and VZV encephalitis, increased risk of death, and sequels. The empirical treatment currently recommended, aciclovir and amoxicillin, is appropriate for this age group.